Back to results
US 10,504,613 B2Granted
Methods and processes for non-invasive assessment of genetic variations
AssigneeSequenom, Inc.
InventorsSung K. Kim, Cosmin Deciu
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations.
Claims20
A computer-implemented method for classifying nucleic acid for a fetal aneuploidy, comprising:
- (a) identifying a subset of genomic sections of a reference genome consisting essentially of genomic sections to which an enriched amount of reads from fetal nucleic acid fragments are mapped by a process comprising:
- (i) sequencing circulating cell-free nucleic acid from each sample from a group of pregnant females by a sequencer that generates sequence reads for each of the samples of the group;
- (ii) measuring, for each of the samples of the group, the length of each fragment in the circulating cell-free nucleic acid from which each of the sequence reads originated using a microprocessor;
- (iii) computing, using a microprocessor, a fragment length ratio X/Y for each genomic section for each sample, wherein:
- (1) X is the sum of reads that (i) map to the genomic section, and (ii) are from nucleic acid fragments that are shorter than a first selected fragment length;
- and
- (2) Y is the sum of reads that (i) map to the genomic section, and (ii) are from nucleic acid fragments that are shorter than a second selected fragment length, wherein the second selected fragment length is longer than the first selected fragment length;
- (iv) computing an average fragment length ratio for each genomic section;
- (v) determining a median fragment length ratio for a plurality of genomic sections;
- and
- (vi) selecting the subset of genomic sections based on each genomic section of the subset having an average fragment length ratio that is greater than the median fragment length ratio;
- (b) sequencing circulating cell-free nucleic acid from a test sample from a pregnant female bearing a fetus by a sequencer that generates sequence reads for the test sample;
- (c) mapping, using a microprocessor, the test sample sequence reads to the subset of genomic sections selected in (a)(vi);
- (d) calculating, using a microprocessor, the amount of test sample sequence reads mapped to the subset of genomic sections;
- (e) outputting a classification of presence or absence of a fetal aneuploidy according to the amount determined in (d).
12 more elements
Dependencies are inferred from the claim text.